Condition 101 About Allergic Bronchopulmonary Aspergillosis

What is the definition of Allergic Bronchopulmonary Aspergillosis?

Allergic bronchopulmonary aspergillosis is an allergic lung reaction to a type of fungus (Aspergillus fumigatus). Symptoms vary, but may include wheezing, bronchial hyperreactivity, hemoptysis, productive cough, low-grade fever, malaise, and weight loss. It is more common in people who have asthma or cystic fibrosis. The recommended treatment for allergic bronchopulmonary aspergillosis is itraconazole, a prescription antifungal medication. Oral corticosteroids, like prednisone, may also be helpful. The clinical course of allergic bronchopulmonary aspergillosis is variable. Many people with this condition can be stabilized for long periods when treated. However, only about 50% of patients achieve long-lasting remission and many require recurrent courses of treatment.

What are the alternative names for Allergic Bronchopulmonary Aspergillosis?

  • ABPA
  • Allergic bronchopulmonary mycosis
  • Aspergillosis, allergic bronchopulmonary
  • Hinson-Pepys disease

Top Global Doctors For Allergic Bronchopulmonary Aspergillosis

Latest Advances On Allergic Bronchopulmonary Aspergillosis

  • Condition: Allergic Bronchopulmonary Aspergillosis
  • Journal: International archives of allergy and immunology
  • Treatment Used: Omalizumab
  • Number of Patients: 25
  • Published —
In this study, researchers evaluated the safety and effectiveness of using omalizumab for the treatment of allergic bronchopulmonary aspergillosis in patients with chronic bacterial infections in the airways.
  • Condition: Mycobacterium Avium Complex Lung Disease
  • Journal: Respiratory medicine
  • Treatment Used: Aspergillus Precipitating Antibody Test
  • Number of Patients: 131
  • Published —
This study tested the safety and efficacy of using an aspergillus precipitating antibody test to diagnose patients with mycobacterium avium complex lung disease.

Clinical Trials For Allergic Bronchopulmonary Aspergillosis

Clinical Trial
  • Status: Recruiting
  • Participants: 25
  • Start Date: November 15, 2021
Immune Profiles in CF Fungal Infection
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 170
  • Start Date: September 15, 2020
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis